SCHEMBL7424713

SCHEMBL7424713

O=C(Cc1ccccc1)NOCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.62
RAB9A P51151 6/20 0.62
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
CASP1 P29466 1/20 0.53
EGFR P00533 1/20 0.53
ALDH1A1 P00352 3/20 0.53
MAPK1 P28482 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
EPHX2 P34913 1/20 0.53
HDAC3 O15379 1/20 0.52
NCOR2 Q9Y618 1/20 0.52
KDM4E B2RXH2 1/20 0.51
LMNA P02545 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14812337 0.90 CNR2 (0.54) NPC1RAB9AMEN1KMT2AHDAC8
SCHEMBL14812072 0.89 EPHX2 (0.65) NPC1RAB9AMEN1KMT2AHDAC8
SCHEMBL4917828 0.87 RAB9A (0.68) NPC1RAB9AEGFRALDH1A1L3MBTL1
SCHEMBL14811905 0.87 EPHX2 (0.54) NPC1RAB9AMEN1KMT2AHDAC8
SCHEMBL7981993 0.85 HDAC3 (0.64) NPC1RAB9AEGFREPHX2HDAC3
SCHEMBL7970712 0.85 NPC1 (0.62) NPC1RAB9AEGFREPHX2HDAC3
SCHEMBL906398 0.85 RAB9A (0.62) NPC1RAB9AKMT2AEGFRALDH1A1
SCHEMBL9800175 0.85 NPC1 (0.62) NPC1RAB9AEGFRALDH1A1EPHX2
SCHEMBL13607002 0.85 NPC1 (0.62) NPC1RAB9AEGFRALDH1A1EPHX2
SCHEMBL7381527 0.83 NPC1 (0.61) NPC1RAB9AEGFREPHX2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101370790-B As pyridine and the pyrimidine derivatives of NSC 630176 JANSSEN PHARMACEUTICA N.V. (BE) 2015-10-21 CN disclosed
EP-2810944-A1 HETEROCYCLIC COMPOUND HAVING ANTI-HIV ACTIVITY Toyama Chemical Co., Ltd. (JP) 2014-12-10 EP disclosed
CN-101370804-B Novel aminophenyl derivatives as histone deacetylase inhibitors JANSSEN PHARMACEUTICA NV 2013-05-29 CN disclosed
CN-101370789-B Pyridine and pyrimidine derivatives as histone deacetylase inhibitors JANSSEN PHARMACEUTICA NV 2012-05-30 CN disclosed
CN-101370791-B Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase JANSSEN PHARMACEUTICA NV 2012-05-02 CN disclosed
CN-1993353-B Substituted indolyl alkylamino derivatives as novel inhibitors of histone deacetylase JANSSEN PHARMACEUTICA NV 2010-12-01 CN disclosed
CN-101370789-A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase JANSSEN PHARMACEUTICA NV (BE) 2009-02-18 CN disclosed
CN-101370790-A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase JANSSEN PHARMACEUTICA NV (BE) 2009-02-18 CN disclosed
CN-101370804-A Novel aminophenyl derivatives as histone deacetylase inhibitors JANSSEN PHARMACEUTICA NV (BE) 2009-02-18 CN disclosed
CN-101370791-A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase JANSSEN PHARMACEUTICA NV (BE) 2009-02-18 CN disclosed
CN-1993353-A Substituted indolyl alkylamino derivatives as novel inhibitors of histone deacetylase JANSSEN PHARMACEUTICA NV (BE) 2007-07-04 CN disclosed
WO-2001019373-A2 METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS BASF AKTIENGESELLSCHAFT (DE) 2001-03-22 WO disclosed
CN-1269722-A Method and composition for modulating responsiveness to corticosteroids BASF AG (DE) 2000-10-11 CN disclosed
EP-0998300-A1 METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS BASF AKTIENGESELLSCHAFT (DE) 2000-05-10 EP disclosed
US-5919790-A ANTIINFLAMMATORY AGENT; THERAPY FOR STROKE, SEPTIC SHOCK;ALZHEIMER*S DISEASE WARNER-LAMBERT COMPANY (US) 1999-07-06 US disclosed
WO-1998041232-A2 COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS BASF AKTIENGESELLSCHAFT (DE) 1998-09-24 WO disclosed